address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,longName,shortName,exchange,messageBoardId,marketState,corporateActions,regularMarketTime,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,regularMarketChangePercent,regularMarketPrice,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,trailingPegRatio
GSK House,Dr. Annie Besant Road Worli,Mumbai,400030,India,91 22 2495 9595,91 22 2495 9494,https://india-pharma.gsk.com,Drug Manufacturers - General,drug-manufacturers-general,Drug Manufacturers - General,Healthcare,healthcare,Healthcare,"GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. It provides vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella, and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also offers specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.",3113,"[{'maxAge': 1, 'name': 'Mr. Bhushan  Akshikar', 'title': 'MD & Executive Director', 'fiscalYear': 2025, 'totalPay': 63505000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Juby  Chandy', 'age': 46, 'title': 'Whole-Time Director & CFO', 'yearBorn': 1978, 'fiscalYear': 2025, 'totalPay': 59608000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Aparajita  Rajput', 'title': 'Vice President of Technology', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ajay Avinash Nadkarni', 'title': 'VP of Administration & Real Estate and Company Secretary', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Amit G. Pandey', 'title': 'Executive Vice President of Legal', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Simrat  Sohal', 'title': 'Vice President of Ethics & Compliance', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Carson  Dalton', 'title': 'Executive Vice President of Communications & Government Affairs', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chinmay  Sharma', 'title': 'Executive Vice President of Human Resources', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sukanya  Choudhary', 'title': 'Head of Growth Emerging Market', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sharmishta  Mitra', 'title': 'Commercial Head - Paediatric Vaccines', 'fiscalYear': 2025, 'exercisedValue': 0, 'unexercisedValue': 0}]",1767139200,[],86400,2,3199.2,3190.2,3176.0,3255.0,3199.2,3190.2,3176.0,3255.0,42.0,1.31,1748563200,0.5844,1.7,0.038,58.736977,55.500862,123887,123887,214066,120621,120621,0.0,0.0,0,0,544386187264,1921.0,3515.7,14.520021,3027.776,2614.9187,42.0,0.0131282825,INR,False,517082251264,0.24741,41287639,169406000,0.75,0.08704001,175263008,115.185,27.898598,1743379200,1774915200,1743379200,0.352,9275829248,54.71,57.9,2:1,1536624000,13.792,44.858,0.26071882,0.094471335,42.0,1748563200,EQUITY,3213.5,3500.0,2600.0,3072.0,3094.0,2.25,buy,4,24981035008,147.462,11527068672,99512000,1.501,1.79,37492105216,0.51,221.315,0.18173,0.4975,23353583616,11623792640,12898973696,0.352,0.048,0.62289,0.30745,0.33073002,INR,GLAXO.NS,en-US,US,Equity,Delayed Quote,True,HIGH,GlaxoSmithKline Pharmaceuticals Limited,GLAXOSMITHKLINE PHARMA LT,NSI,finmb_878375,POSTPOST,[],1750413600,Asia/Kolkata,IST,19800000,in_market,False,185.72412,0.061340116,598.5813,0.2289101,15,15,2.3 - Buy,0.44698828,3213.5,False,False,1025495100000,14.300049,3176.0 - 3255.0,NSE,214066,1292.5,0.67282665,1921.0 - 3515.7,-302.19995,-0.08595727,26.071882,1747133940,1753959540,1754308800,1747133940,1747133940,True,54.71,57.9,61.375,52.35845,
